These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 17028580)
1. Probing cell-division phenotype space and Polo-like kinase function using small molecules. Peters U; Cherian J; Kim JH; Kwok BH; Kapoor TM Nat Chem Biol; 2006 Nov; 2(11):618-26. PubMed ID: 17028580 [TBL] [Abstract][Full Text] [Related]
2. Inhibitors of Polo-like kinase reveal roles in spindle-pole maintenance. McInnes C; Mazumdar A; Mezna M; Meades C; Midgley C; Scaerou F; Carpenter L; Mackenzie M; Taylor P; Walkinshaw M; Fischer PM; Glover D Nat Chem Biol; 2006 Nov; 2(11):608-17. PubMed ID: 17028581 [TBL] [Abstract][Full Text] [Related]
3. Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology. Schöffski P Oncologist; 2009 Jun; 14(6):559-70. PubMed ID: 19474163 [TBL] [Abstract][Full Text] [Related]
4. Polo-like kinase 1 inhibitors in mono- and combination therapies: a new strategy for treating malignancies. Christoph DC; Schuler M Expert Rev Anticancer Ther; 2011 Jul; 11(7):1115-30. PubMed ID: 21806334 [TBL] [Abstract][Full Text] [Related]
5. Xenopus Cep57 is a novel kinetochore component involved in microtubule attachment. Emanuele MJ; Stukenberg PT Cell; 2007 Sep; 130(5):893-905. PubMed ID: 17803911 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of pyrido-thieno-pyrimidines as potent and selective Cdc7 kinase inhibitors. Zhao C; Tovar C; Yin X; Xu Q; Todorov IT; Vassilev LT; Chen L Bioorg Med Chem Lett; 2009 Jan; 19(2):319-23. PubMed ID: 19071019 [TBL] [Abstract][Full Text] [Related]
7. Dynamics of the mitotic spindle--potential therapeutic targets. Miyamoto DT; Perlman ZE; Mitchison TJ; Shirasu-Hiza M Prog Cell Cycle Res; 2003; 5():349-60. PubMed ID: 14593729 [TBL] [Abstract][Full Text] [Related]
8. Novel pyrimidine-2,4-diamine derivative suppresses the cell viability and spindle assembly checkpoint activity by targeting Aurora kinases. Salmela AL; Pouwels J; Mäki-Jouppila J; Kohonen P; Toivonen P; Kallio L; Kallio M Carcinogenesis; 2013 Feb; 34(2):436-45. PubMed ID: 23104179 [TBL] [Abstract][Full Text] [Related]
10. Rotenone inhibits mammalian cell proliferation by inhibiting microtubule assembly through tubulin binding. Srivastava P; Panda D FEBS J; 2007 Sep; 274(18):4788-801. PubMed ID: 17697112 [TBL] [Abstract][Full Text] [Related]
11. A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity. Montagnoli A; Valsasina B; Croci V; Menichincheri M; Rainoldi S; Marchesi V; Tibolla M; Tenca P; Brotherton D; Albanese C; Patton V; Alzani R; Ciavolella A; Sola F; Molinari A; Volpi D; Avanzi N; Fiorentini F; Cattoni M; Healy S; Ballinari D; Pesenti E; Isacchi A; Moll J; Bensimon A; Vanotti E; Santocanale C Nat Chem Biol; 2008 Jun; 4(6):357-65. PubMed ID: 18469809 [TBL] [Abstract][Full Text] [Related]
12. Small molecules keep mitotic kinases in check. Strebhardt K ACS Chem Biol; 2006 Dec; 1(11):683-6. PubMed ID: 17184131 [TBL] [Abstract][Full Text] [Related]
13. Mitotic drivers--inhibitors of the Aurora B Kinase. Keen N; Taylor S Cancer Metastasis Rev; 2009 Jun; 28(1-2):185-95. PubMed ID: 19189202 [TBL] [Abstract][Full Text] [Related]
15. Substituted 2-arylbenzothiazoles as kinase inhibitors: hit-to-lead optimization. Tasler S; Müller O; Wieber T; Herz T; Pegoraro S; Saeb W; Lang M; Krauss R; Totzke F; Zirrgiebel U; Ehlert JE; Kubbutat MH; Schächtele C Bioorg Med Chem; 2009 Sep; 17(18):6728-37. PubMed ID: 19692247 [TBL] [Abstract][Full Text] [Related]
16. Novel Mps1 kinase inhibitors: from purine to pyrrolopyrimidine and quinazoline leads. Bursavich MG; Dastrup D; Shenderovich M; Yager KM; Cimbora DM; Williams B; Kumar DV Bioorg Med Chem Lett; 2013 Dec; 23(24):6829-33. PubMed ID: 24183538 [TBL] [Abstract][Full Text] [Related]
17. Validation of a flow cytometry based G(2)M delay cell cycle assay for use in evaluating the pharmacodynamic response to Aurora A inhibition. Estevam J; Danaee H; Liu R; Ecsedy J; Trepicchio WL; Wyant T J Immunol Methods; 2011 Jan; 363(2):135-42. PubMed ID: 20887727 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of alpha-hydroxymethylated conjugated nitroalkenes for their anticancer activity: inhibition of cell proliferation by targeting microtubules. Mohan R; Rastogi N; Namboothiri IN; Mobin SM; Panda D Bioorg Med Chem; 2006 Dec; 14(23):8073-85. PubMed ID: 16891118 [TBL] [Abstract][Full Text] [Related]
19. Aminopyrimidinone cdc7 kinase inhibitors. Woods KW; Lai C; Miyashiro JM; Tong Y; Florjancic AS; Han EK; Soni N; Shi Y; Lasko L; Leverson JD; Johnson EF; Shoemaker AR; Penning TD Bioorg Med Chem Lett; 2012 Mar; 22(5):1940-3. PubMed ID: 22326396 [TBL] [Abstract][Full Text] [Related]
20. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Mayer TU; Kapoor TM; Haggarty SJ; King RW; Schreiber SL; Mitchison TJ Science; 1999 Oct; 286(5441):971-4. PubMed ID: 10542155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]